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Abstract  
  
Older people with diabetes mellitus type II are more likely to develop hyperosmolar non-ketotic 
coma and have worst outcomes, like higher mortality than middle-aged people with diabetes 
mellitus type II.  To prevent and control diabetes mellitus type II and complications for older 
adults by decreasing HbA1c and increase medication adherence and self-care behavior. Older 
adults who are unfunctional of their cognitive impact because of the process of ageing impaired 
cognitive behavior. To review the evidences of medication adherence in older adults with type 
II Diabetes Mellitus.The selection process of the articles have been done by using this data based 
provided  by Prince of Songkla University. The data base was selected for this study are Cinanhl, 
Proquest, Science Direct, and PubMed. By using this data base the search terms according to 
PICO a total of eighty (80) have been found. From the overall thirtieth (30) relevant articles 
closely related to this study. Five studies were reviewed with two types of interventions for 
medicaiton adherence in older adult patients: Patient education (teaching), and  nurse telephone 
call intervention. The result from this  five studies the intervention successfully improved 
medication adherence in older adults patients. Diabetes mellitus is one of the most world wild 
prevalent of chronic disease, where it increasing globally to such a high levels. The management 
of lower blood glucose level is depend on many factors, including the management of diabetes 
mellitus in patient’s health education in knowledge, and practice on medication adherence.  
Patient’s ability to do self-care in their daily lives, and therefore patients education in knowledge, 
attitude, and practice on medication adherence is considered an essential element of diabetes 
management. Patient’s education and knowledge is an important component in management of 
diabetes in medication adherence.   
Keywords:  Medication adherence, type II diabetes, older adults 
 
I.  INTRODUCTION  
  
iabetes mellitus is an endocrine 
disorder, characterized by 
hyperglycemia that caused high blood 
sugar levels (Rahman, Basunia, Khan, & Nag, 
2005). Diabetes is a common and serious 
problem and it occurs all around the world. 
Diabetes can occur in men, women and all age 
of groups. The world prevalence of diabetes 
among adults to elderly (aged 20–79 years) is 
estimated to be 6.4% in 2010 and will increase 
to 7.7% by the year 2030 (Shaw, 2010). In 
Indonesia, the prevelance of diabetes mellitus 
was about 8.4 million in 2000 and is projected 
to increase up to 21.3 million in 2030 
(Widjojo, 2011). The World Health 
Organization (WHO) has predicted that the 
worldwide prevalence of diabetes mellitus 
will increase to 300 million by the year 2025 
(Pradeepa, 2002).  The prevalence of diabetes 
in older adults is high in US, 29 % of people > 
65 years old are diagnosed with diabetes 
mellitus (National diabetes fact sheet, 2011). 
As United States population ages and the rate 
of individual who are overweight of obesity 
continue to rise, both the prevalence and 
burden of diabetes in the elderly is expected to 
increase substantially over the next decades 
(Imperatore, Boyle, Thompson, Case, 
Dabelea, Hamman & Standiford, 2012).  
The American Diabetes Association 
(ADA) recommends that glycemic goals for 
elderly patients with diabetes should be 
individualized, based on the presence or 
absence of cognitive impairment, funtional 
impairment, major comorbidities and limited 
life expectancy (Inzucchi,et al, 2012). 
However elderly people who tend to be less 
obese and are more likely to have significantly 
impaired insulin than people with middle-aged 
type II diabetes mellitus (Morley & Perry, 
1991). Futhermore, ageing appears to interact 
with hyperglycemia to accelerate the onset of 
late diabetes complications, such as 
retinopathy and nephropathy, with thier onset 
occurring within 5 years of diagnosis of 
diabetes. Older people with diabetes mellitus 
type II are more likely to develop 
hyperosmolar non-ketotic coma and have 
worst outcomes, like higher mortality than 
D 
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middle-aged people with diabetes mellitus 
type II. There are several evidence have been 
proven that a good control of glucose will have 
a good quality of life (Morley, 1998).   
 
The medical management of olderly adults 
with diabetes type II is challenging  due to 
several factors such as olderly adults are more 
likely to have diabetes that is complicated by 
end-organ damage and in general, long 
duration of disease is  associated with 
defective glucose counter-regulation leading 
to increased risk of hypoglycemia  (Chiang, 
Kirkman, Laffel & Peters, 2014). Therefore 
there are many interventions programs to 
prevent and control diabetes mellitus type II 
and complications for eldery people by 
decreasing HbA1c by doing a good lifestlye 
such as using delivery meals and dietary 
counseling to reduce body weight, exercise to 
reduce  the proportion of metabolic syndrome, 
and using diabetes empowerment to increase 
medication adherence and self-care behavior 
(Saengtipbovorn & Taneepanichskul, 2014). 
The maintanance of lower blood glucose level 
is depend on many factors, including the 
intervention programs of diabetes mellitus 
type II. The management of diabetes mellitus 
depends on patients ablitity to do self-care on 
medication adherence in their daily lives and 
considerd medication adherence as an 
essential elements of diabetes management 
(AlMaskari, 2013).  Medication Adherence is 
defined as a terms of person’s behavior in 
taking medications, following  diets, or 
changing  lifestyle with medical or health 
device (Morisky,  Green, & Levine, 1986) and 
has extent to which patients take medicaitons 
as presribed by thier healthcare providers 
(Jimmy, Al-Hinai, Wadair & Al-Amri, 2014). 
Low of medication adherence has become a 
key health care issue as it greatly effects the 
benefits of medical care and improves a 
significant financial burden on the individual 
patient and health care system as a whole 
(Mahesh & Parthasarathi, 2004).  The 
medication knowledge consisted of five 
spesific items of information regarding the 
patient’medications: name, dose, frequency, 
indication, and how the patient administerd 
the medications which eldery people with 
diabetes mellitus type II should know and 
understand about the five spesific items of 
information  (Krousel-Wood, Thomas, 
Muntner & Morisky, 2004).  
Older adults who are unfunctional of their 
cognitive impact have a signigicnat expectory 
must receive diabetes care and the most 
problem in dealing with older adults is they 
tend to forget to take medication that are 
recommended by the health providers that is 
because of the process of ageing impaired 
cognitive behavior (Mahesh & Parthasarathi, 
2004). For this problem the researcher want to 
know what is the best intervention for this 
problem, so the older adult able to consumed 
medication regulary and they can have a good 
quality of life.   
 
METHOD  
  
Review of the literature involved  
ProQuest, CINAHL, Pubmed, and Science 
searched for relevant articles published 
through the year 1997-2014  
All the clinical trials are randomized 
control trials, experiment study, and quasi 
experiment, review articles were eligible 
according to the inclusion criteria. The articles 
for full text was also indentified. The relevant 
articles were graded by using of 
recommendation based on JBI, 2014.   
  
RESULTS  
  
The selection process of the articles have 
been done by using this data based provided  
by Prince of Songkla University. The data 
base was selected for this study are Cinanhl, 
Proquest, Science Direct, and PubMed. By 
using this data base the search terms according 
to PICO a total of eighty (80) have been found. 
The selection proses was done by re-read the 
abstract of each articles to make sure the 
articles meet with the inclusion criteria of this 
study.   
From the Cinanhl data base, a total of 
thirtieth (30) articles were found. After re-read 
the abstract and skimming the whole articles, 
only ten articles were found related to this 
study. From tweenty articles was found by 
using the proQuest data base, only tweenty 
(20) were found, only ten (10) articles was 
relevant to this study. The searching articles 
using Science Direct database, only ten (10) 
articles was found and only five (5) articles are 
related to this study. While from PubMed, a 
number of ten (10) articls were found, related 
to this study only five (5) articles.   
The articles  that are relevant to this study 
was re-read and analyse carefully to 
synthesize the methodology. From the overall 
thirtieth (30) relevant articles closely related 
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to this study.   
 
Concept of Medication Adherence  
Adherence is defined as the extent in 
which the patients follow the instructions of 
the health care providers in practice and the 
disired of health behaviors that will achive 
agreement between the health care providers 
and patients. Adherence focusses on the 
participants behavior of following the 
recommendation in order to produce an 
optimal outcome (Osterberg & Blaschke,  
2005).   
Medication adherence is the continous of 
administrating medicine from the first dose 
to the last dose without stoping drinking  any  
medication beside the health care providers 
tells the patient to stop drinking the medicine 
or there is a agreement between the healtlh 
care provider and patients (Haynes, Yao, 
Degani, Kripalani & McDonald, 2005).   
Medication adherence for the older adults 
with diabetes mellitus type II can be 
classified into four components such as (1) 
voluntary willingeness, (2) active 
participation, (3) persistence in following 
prescription and (4) continuity duration of 
the theraphy   
(Novityani, 2013).  
 Voluntary willingness  refers the 
agreement of the patients in consuming 
medicines as recommended by the health 
care providers. It aslo the patients role for 
agreeing to consume medicine after the 
patients understands the required information  
about mechanism, side effect, dosis, and 
frequency of the medicine they consumed 
(Cohen, 2009).  Active participants  is the 
patients behaviors in responsible consume 
medicine and they are expected to prepare 
thier own medicine, keep them in a proper 
place, remember the dose and the timming in 
drinikin medicine, and remember the next 
appointment with the health providers 
(Novityani, 2013). Persistence  indicates  the 
patients prescription of taking medicines as 
precribed by the health provider with the 
correct type of medicine, correct dose, and 
correct frequency, and at the right time. 
Contuinity in medication adherence refers to 
the medicine untul the last dose as describe 
by the health providers with out missing any 
medicine (Novitayani, 2013).   
 
Associated Factors  Demographic factors   
Demographic factors is one factors 
accosiated with medication adherence.  
Demographic factors such as ethnic monority, 
age, gender, race, low socioeconomic status, 
and low levels of education have been 
associated with lower regimen adhrence and 
greater diabetes-related morbidity (Delamater, 
Jacobson, Anderson, Fisher, Lustman, Rubin 
& Wysocki, 2001; Balkrishnan,  Bhosle, 
Camacho & Anderson, 2006; Peyrot, Rubin, 
Lauritzen, Snoek, Matthews & Skovlund).   
The effect of age on mediation it would 
appear  to the effect of age  could be divided 
into 3 major groups: the elderly group (over 55 
years old), the middle- age group (20 to 54 
years old), and the young group (under 40 
years old) (Jin, Sklar & Li, 2008). Certain 
studies reported that  age affected medication 
adherence among older adults because of 
problems with visions, hearing, memory and 
have more diffuculties in following 
instructions due to cognitive impairment or 
other physical difficulties, such as problems 
with swallowing tablets, opening the drug 
containers, distinguish colors,  and identifying 
makings on drugs (Balkrishnan, Bole, 
Camacho & Anderson, 2006).  
Another study also had found  that gender 
has not been found to influence medication 
adherence on adhrence to oral  anti-diabettic 
mediations (Peyrot, Rubin, Lauritzen, Snoek, 
Matthews & Skovlund 1999).   
 
Psychological factors  
Psychological factors are also linked with 
regimen adherence because of patient’s 
beliefs, motivation, and negative attitude 
towards theraphy (Jin, Sklar & Li, 2008)). 
Another reseracher has also found Peytro, 
Mchurry & Kruger, (1999) that patients with a 
good adherence will make sense to them, 
when it seems effective, when they believe the 
benefits exceed the costs, when they feel that 
they  have the ability to succeed, and when 
their environment supports.  Higher levels of 
stress and maladaptive coping have been 
associated with more adherence problems. 
Psychological problems such as anxiety, and 
depression have also been linked with worse 
diabetes management in older adults with 
diabetes mellitus (Peytro, Mchurry & Kruger, 
1999).     
  
Social factors  
Social factors play an important role in 
diabetes management, because patients who 
had emotional support and help from the 
family members, friends, or even health care 
providers were more adherence to the 
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treatment (Delameter Jacobson, Anderson, 
Cox , Fisher, Lust man, Rubin, Wysocki, 
2001; Nagelkerk, Reick & Meengs, 2006).  
Social support may help patients in reducing 
negative attitudes to the treatment, giving 
patients motivation and remembering the 
patients to follow all treatment (Jin, Sklar & 
Li, 2008).   
 
Health care system factors  
The main factor relating to health care 
provider include avaibility and accessibility 
lack of accesibility to health care, long 
waiting time for clinic visits, and unhappy 
clinic visits all of these contribute to poor 
adherence (Jin, Sklar & Li, 2008).  It was 
observed that the diabetes control and 
complications one of the key elements to 
success in achieving good glycemic control 
was supported the helth care provider. In 
addition the ability to obtain support from the 
care team members, the quality of  the 
patient-docter relationship is very important 
determinant of regimen adherence (Auber et 
al, 2002).   Disease and treatment related 
factors  
 
Research has generally shown that 
lower regimen adherence can happened when 
health condition is chronic, when the course 
of symptoms varies or when a regimen is 
more complex, and when a treatment 
regimen requires lifestyle changes (Jin, Sklar 
& Li, 2008).   
Treatment related factor asssociated with 
non- adherence in the management of type II 
diabetes include the number of medications 
(Pill burden), side effects, dosage, frequency, 
and the cost.  While it is generally believed 
that diabetic patients who take multiple 
medicaitons are less adherent to their diabetic 
regimens, the litarature has conflicting 
information (Mahesh, 2004).     
 
Knowledge factors   
Patients knowledge about thier disease 
and treatment  is an important factors to 
control medication adhrence (Xu, Tolbert, 
Savage, Pan, & Whiter, 2008; Omar & San, 
(2014). Some patients lack of understading 
the role of the treatment, others lack of 
understanding the value of clinical visit (Jin, 
Sklar & Li, 2008). For these reason patient’s 
education is important to enchance 
medication adherence, and a good 
knowledge is one of the sources of self-
efficacy to self-management of dietary 
behaviors (Xu, Tolbert, Savage, Pan, & 
Whiter, 2008). Another study from Omar & 
San, (2014) have found that the knowledge 
the patient need is related to obedience in 
consuming medicine in the right time and 
right dosis without missing any medication.  
The knowledge of the patients in consuming 
medicine, and have a good lifestlye would 
faster the strategies ability of patients to 
medication adherence.   
 
Measurement of Medication Adherence   
Medication adherence influenced by much 
different kind of factors it is measurement is 
often unreliable, costly or time consuming. 
There are three main methods of measuring 
medication adherence. These includes clinical 
self-report (Questionnaire), pill counts, and 
Morisky Medication Adherence Scale 
(MMAS) (Thompson, Kulkarni & Sergejew,  
2000).   
 
Self-reporting  
Methods for patients self-reporting 
include: (1) patients-kept diaries (2) patients 
interview, with specific questions regarding 
the accuracy of medication adherence (3) 
standard, validated, adherence specific 
questionnaire. (Farmer, 1999).    
The instrument has three sets of questions: 
four regimen screen items: two belief screen 
items; and two recall screen items.  For 
regimen screen items, each medication list 
consist of four questions: “How many days did 
you take it?”, “How many times per day did 
you take it?’’, “how many pills did you take a 
day?’’ how many times did you miss taking a 
pill?’’.  Belief screen consist of two questions: 
“How well does this medication work for you 
“? “ This medication work for you” Recall 
screen, consist of one questions: “How hard is 
it for you to remember to take all the pills?” 
(Svarstad, Chewning, Sleath, & Claesson, 
1999).  
 
Pill counts   
A pill count is simply counting the number 
if dosage units like tablets, and capsule. This 
provides the amount of medication used by the 
patient during this time. The amount used 
divided by the expected amount and 
multiplied by 100 to determine the percentage 
of compliance. For instance, a patient returns 
12 tablets 30 days after receiving 60 tablets. 
The medication taken twice daily; therefore, 
60 units should be consumed over a 30-day 
period. The compliance ratio is then calculated 
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as (60 - 12) / 60 x 100 = 80%. Another method 
for measuring. The use of pill counts to assess 
adherence also has other informational 
drawbacks. Even when accurate, pill counts 
can only document adherence as a percentage 
of total consumption. They cannot provide 
information regarding the nature of the 
adherence problem (the pattern of missed 
doses) or the reasons for the problem (side 
effects) (Farmer, 1999).   
 
Morisky  Medication  Adherence 
 Scales (MMAS)  
MMAS is the subjective method of 
adherence assessment tool in patients with 
diabetes which is developed by Morisky 
in1986. It a multi item scale consisting of 4 
items that measures medication 
nonadherence due to 4 patient related barriers 
such as forgetfulness, carelessness, feeling 
better and feeling worse but the reliability of 
this tool was low with Cronbach’s alpha of 
.61. The tool was modified by Krousel Wood 
et al.in 2009.   
This modified version of MMAS consists 
of 8 items assessing the behavior of 
medication taking rather than the factors 
affecting adherence. The seven items in the 
questionnaire have replies in the dichotomial 
form of ‘yes’ or ‘no’and one of the items 
(how often do you have difficulty to 
remember to take medicines) is rated on 5-
point Likert type scale. The total score that 
can be obtained from the tool is 12 and the 
lowest score is 1. Higher the score it can be 
assumed that better is the adherence to 
medication. Further, the scores are 
categorized with 3 cut points to interpret 3 
levels of adherence such as low adherence 
(less than 6), medium adherence (6to 8) and 
high adherence (more than 8). The 
Cronbach’s alpha was determined to be .83 
for the new tool which is much better than the 
original one (Krousel-Wood et al., 2009).  
 
Intervention  to  improve 
 medication adherence  
In order to achieve the desired goals of 
therapy in the management of patients 
presenting with type 2 diabetes, considerable 
attention must be given towards improving 
individual patient’s adherence to his/her 
prescribed medications. Five studies were 
reviewed with two types of interventions: 
Patient education (teaching), and  nurse 
telephone call intervention ( Davies,  Heller, 
Skinner, Campbell, Carey, Cradock & 
Khunti,   
2008; Zullig, Gellad, Moaddeb, Crowley, 
Shrank, Granger & Bosworth, 2015; Tessier & 
Lassmann-Vague, 2007; Osterberg & 
Blashacke, 2005;  Kim & Oh, 2003; Alisha, 
Asgari, Khayeri, Ramazani, Farajzadegan, & 
Javaheri, 2013).  
 
Patient education   
Patient education can be used to improve 
the adherence. The educational intervention 
involving patients, thier family members, or 
both can be effective in improving adherence 
(Osterberg & Blashacke, 2005).  
 
The study done by (Davies,  Heller, Skinner, 
Campbell, Carey, Cradock & Khunti,  2008). 
This study foussed on the effectiveness of 
group education programme in older adult 
patients with type diabetes mellitus type II. 
The samples were 834 older adults.  The 
intervention of patients education will be held 
for six hours long  delivered in either one day 
or two half day equivalent and facilitated by 
two educators. The session which covers the 
patients thoughts and feeling of the disease of  
diabetes, Understanding diabetes and glucose: 
what really happens in the body,  
Understanding  more about the importance of 
medication for diabetes and about how to 
monitor diabetes, and how to have a good 
lifestyle, and also disscusion; asking 
questions, showing video about diabetes 
mellitus, and practicing with patient about 
consuming medication. (Davies,  Heller, 
Skinner, Campbell, Carey, Cradock & Khunti,  
2008). And the researcher would follow-up 
every 2 weeks and this program will last for 3 
month.  The result of this patient education 
Patients in the intervention group had a mean 
decrease of in HbA1c levels and those in the 
control group had a mean increase of in 
HbA1c levels. The intervention group had 
greater diet and blood glucose testing 
adherence than the control group. These 
findings indicate that the nurse intervention 
can improve HbA1c and diet and blood 
glucose testing adherence.  This means that the 
intervention improved the medication 
adherence.   
The study done by Zullig, Gellad, 
Moaddeb, Crowley, Shrank, Granger & 
Bosworth, (2015) conducted the information 
of education improving medication adherence 
for older adults. The intervention, a 
community health nurse conducted three 
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weekly 20-minute educational sessions. The 
interventionist  used “teach back” to confirm 
the patient’s understanding. For example, 
“When you get home and your [partner] asks 
what the [doctor] said today, what will you tell 
them?” Patients in the pictorial image group 
were given the educational content via simple 
illustrated content. At the conclusion of the 
3week study the mean scores for knowledge, 
adherence to medication (measured using the 
8-item Morisky Medication Adherence Scale), 
and diet were significantly improved in the 
intervention relative to the control groups; 
these differences persisted 6 weeks after the 
intervention.  
The result from this study the intervention 
successfully improved medication 
adherence, which was evaluated using 
pharmacy refill data to calculate a medication 
possession ratio. For the intervention group, 
at 6 months medication possession ratio had 
improved from 0.90 to 0.92 (P=0.16) and at 
12 months from 0.85 to 0.90 (P<0.01).  
 Another study by Tessier & 
LassmannVague, (2007) about patient 
education is the  key aspect of diabetes 
mellitus management in older adult. 
Perceptions of the patient, the participants of 
the caregivers, giving motivations of both, 
adapted teaching strategies, are the elements  
where education will improve the diabetes 
mellitus control. A collaborative apporach to 
care patients who have  difficulty with 
adherence need more intensive  strategies 
than the patient who have less difficulty with 
adherence. New technologies such as 
reminders through cell phones or email may 
be used by the patient if they need any help 
to remind them about consuming medicine in 
the right time and living a healthy lifestyle 
(Osterberg & Blashacke, 2005).   
 
Nurse telephone calls   
The study done by Kim & Oh, (2003) 
focussed in the effect of nurse telephone calls 
on glycosylated hemoglobin (HbA1c) levels 
and adherence to diabetes control 
recommendations. The participants in the 
control group were sixthteen people and for 
the experimental group were 20 people so the 
total participants are 36 people.  The goal of 
the intervention was to keep blood glucose 
concentrations close to the normal range 
(HbA1c < 7%). Before the intervention was 
given, the researcher given the patients a 
booklet and a daily log. Each patient was 
instructed about the booklet and daily log for 
40 minuets by the researcher. The booklet 
was 49 pages in length and was given without 
cost to the intervention group.  It was  
contained infomation about the nature of 
disease, risk factors, diet, exercise, drug 
theraphy, hypoglycemia, hyperglycia 
management, and how to record a daily log. 
The telephone intervention was provided to 
the patients for 12 weeks. The 12 week 
intervention consisted of continuing 
education and reinforcement medication 
adjustment recommendations, and living an 
health lifestyle. The researcher contracted 
intervention at least twice a week for the first 
month, and then weekly for the second and 
third month. The frequency of telephone cells 
averaged 16 times  for each patients and the 
duration  for each session was an average 25 
minuets. The call were scheduled when 
convinient to the patient.   
In this study the researcher has found that 
Patients in the intervention group had a mean 
decrease in HbA1c levels and those in the 
control group had a mean increase of in 
HbA1c levels. The intervention group had 
greater diet and blood glucose testing 
adherence than the control group. The 
researcher conclude that a nurse telephone 
intervention can improve HbA1c, diet and 
blood glucose testing adherence, and 
medication adherence.   
Another study by Alisha, Asgari, Khayeri, 
Ramazani, Farajzadegan, & Javaheri, (2013) 
focused on effects of diabetes self-care group 
education and nurse- telephone follow-up on 
glycemic control and compliance with 
treatment orders in patients with type 2 
diabetes attending to diabetes clinic. There 
was 62 patients who attended he diabetes 
clinic selected and were randomly assigned to 
experiment and control groups. Self-care 
group education was applied for case group (n 
= 31) and they were followed up using 
telephone calls for 12 weeks by a nurse. The 
control group (n = 31) received the 
conventional management. Demographic 
characteristics, compliance with treatment 
recommendations (diet, drug use, exercise) 
and blood glucose control indices were 
recorded before and after interventions.  
In this study, group education and 
nursetelephone follow-up calls were as 
independent variables, and fasting blood sugar 
(FBS), blood glucose 2 h after meals, 
glycosylated hemoglobin (HbA1C) and the 
patient's adherence to treatment programs and 
For data gathering there are   two parts 
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questionnaire was used derived from Cheri 
Ann Hernandez study. This questionnaire was 
made of individual and socio demographic 
information section and 13 questions about 
adherence to treatment recommendations. 
Response to questions were classified as 
Likert spectrum consist of always (all of 
week), often (4-5 days a week), sometimes (at 
least three days a week) rarely (1-2 days a 
week) and never (not once a week). The 
results of this study  of the current study self-
care group education and 12 weeks follow-up 
by a nurse using telephone causes significant 
improvement in metabolic parameters and 
adherence to treatment recommendations in 
diabetic patients and in medication adherence.   
 
Conclusion and Recommendations   
Diabetes mellitus type II is characterized as 
a hyperglycemia due to insulin resistance. 
Diabetes mellitus type II very common among 
older adults people and the group that has rate 
of poor glycemic control (Marianas & Kong, 
2014). The main problem of hyperglycemia 
among older adults people is the maintenance 
of lower of blood glucose level and it depends 
on many factors including management of 
diabetes mellitus, and practice on medication 
adherence (Henriquez, Costa & Cabrita, 
2012).  
Medication adherence is a behavior of a 
person in terms of taking medications 
according to agreed recommendations from a 
health care provider. Adherence to medication 
are influenced by several factors such as such 
as group that are accentuated, demographic 
factors, psychological factors, social factors, 
health care provider, disease and treatment 
related factors, and knowledge factors. These 
factor when trying to help older people to 
manage their medication regimen and increase 
adherence with the instruction given, should 
be identified and understood as early as 
possible to be controlled and monitor, in 
formulating strategies to ensure high 
adherence rate (Henriques, Costa & Cabrita, 
2012). Several researcher has found that older 
people who are educated was found higher 
score than does who has low education even 
though they are older adults. The success in 
diabetes mellitus type II management requires 
patient participants must be unsure to receive 
adequate education. The insulin injection 
technique is very important for improvement 
of glycemic control among diabetes mellitus 
type II patients subsequently increased the 
treatment effectiveness of the patient’s 
medication adherence. The effectiveness of 
education intervention has demonstrated to 
increase knowledge adherence among older 
adult patients is patients education level 
(Omar & San, 2014).  In addition, there are 
several tools to assess the medication 
adherence such as; self-report 
(Questionnaire), pill counts, and  
Morisky Medication Adherence Scale 
(MMAS). These tools can be used to measure 
medication adherence for diabetes mellitus 
type II in older adult (Thompson, Kulkarni & 
Sergejew, 2000).   
 
Diabetes mellitus is one of the most world 
wild prevalent of chronic disease, where it 
increasing globally to such a high levels. The 
management of lower blood glucose level is 
depend on many factors, including the 
management of diabetes mellitus in patient’s 
health education in knowledge, and practice 
on medication adherence.  Patient’s ability to 
do self-care in their daily lives, and therefore 
patients education in knowledge, attitude, and 
practice on medication adherence is 
considered an essential element of diabetes 
management. Patient’s education and 
knowledge is an important component in 
management of diabetes in medication 
adherence.   
For the recommendationns, the reasechers 
has limmitation in finding the intervention for 
medication adhrence in older adults, for the 
further must find more studies about the 
interventions for medication adhrence. And 
need more evidence to prove education 
program and telephone calls has improve the 
medication adherence.   
Most of this study is quasi experimental, it 
will be better for the next study to find more 
evidence in a higher level of evidence such as 
RCT systematic review (level Ia, JBI 2014).  
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